Locoregional Treatment Options for Locally Advanced Intrahepatic Cholangiocarcinoma

Inflammatory Bowel Disease

Treatment sequences, outcomes, healthcare utilization, and costs in patients with inflammatory bowel diseases requiring advanced treatment-real world comparative effectiveness from German claims data

BMC Gastroenterol

Dignass A, Teich N, Kaiser S, Sünwoldt J, Dünweber C, Weinhold I, Borchert J, Kudernatsch R

doi: 10.1186/s12876-025-04022-7

Hepatitis

Estimation of the Eligible Population For Resmetirom Among Adults in the United States for Treatment of Non-Cirrhotic NASH with Moderate-to-Advanced Liver Fibrosis

Adv Ther

Fishman J, Kim Y, Charlton MR, Smith ZJ, O'Connell T, Bercaw EM

doi: 10.1007/s12325-024-02989-5

Gastrointestinal Cancer

Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: The ENSCCA registries' framework for digital twin advancement

Hepatology

Carpino G, Overi D, Macias RI, Cardinale V, Izquierdo-Sanchez L, Acedo P, Rengo M, Doukas M, Kendall TJ, Calderaro J, Heij LR, Reichel K, Leone S, Onori P, Franceschini B, Soldani C, Di Tommaso L, Rodrigues PM, Augustin J, Brustia R, Torzilli G, Martin-Izquierdo M, Hernández-Bayo JM, Bueno-Sacristan D, Lanza E, Garcia-Sampedro A, Quaglia A, Ardito F, De Rose AM, Giuliante F, Damato E, Panebianco V, Groot Koerkamp B, Pereira SP, Grazi GL, Alvaro D, Lleo A, Banales JM, Gaudio E

doi: 10.1097/HEP.0000000000001425

Further Publications

Extended Risankizumab Treatment in Patients With Crohn's Disease Who Did Not Achieve Clinical Response to Induction Treatment

Clin Gastroenterol Hepatol

Panaccione R, Ferrante M, Dotan I, Panés J, Hisamatsu T, Bossuyt P, Danese S, Song A, Kalabic J, Joshi N, Zambrano J, Zhang Y, Duan WR, Kligys K, Dubinsky MC, Lindsay JO, Vermeire S, Siegmund B, Irving PM, D'Haens G

doi: 10.1016/j.cgh.2024.12.023

Further Publications

AGA Clinical Practice Update on Advances in Per-Oral Endoscopic Myotomy (POEM) and Remaining Questions-What We Have Learned in the Past Decade: Expert Review

Gastroenterology

Yang D, Bechara R, Dunst CM, Konda VJA

doi: 10.1053/j.gastro.2024.08.038

Gastrointestinal Cancer

First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-305

Adv Ther

Moehler M, Oh DY, Kato K, Arkenau T, Tabernero J, Lee KW, Rha SY, Hirano H, Spigel D, Yamaguchi K, Wyrwicz L, Disel U, Pazo-Cid RA, Fornaro L, Xu Y, Sheng T, Yang S, Kadva A, Cruz-Correa M, Xu RH

doi: 10.1007/s12325-025-03133-7

Pancreas Diseases

Surgical treatment of chronic pancreatitis with an inflammatory pancreatic head mass: a retrospective study

BMC Gastroenterol

Rousek M, Záruba P, Pudil J, Kšírová E, Pohnán R

doi: 10.1186/s12876-024-03338-0

Inflammatory Bowel Disease

Efficacy of Advanced Therapies in Achieving Remission by Disease Location in Crohn's Disease: A Systematic Review and Meta-analysis

Clin Gastroenterol Hepatol

Lee HH, Yuan Y, Boland BS, Chang JT, Jairath V, Singh S

doi: 10.1016/j.cgh.2025.07.009

Gallbladder and Biliary Diseases

Health-related quality of life in participants with advanced biliary tract cancer from the randomized phase III KEYNOTE-966 study

J Hepatol

Yoo C, Ueno M, Klümpen HJ, Kelley RK, Vogel A, Furuse J, Ren Z, Yau T, Chan SL, Ozaka M, Oh SC, Gu S, Park JO, Valle JW, Edeline J, Kim JG, Kamble S, Norquist JM, Yu L, Malhotra U, Finn RS

doi: 10.1016/j.jhep.2025.03.019

Related content